John C. Rose
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 15
-
- Cardiovascular Function and Risk Factors 7
- Heart Rate Variability and Autonomic Control 6
- Nephrology top 5%
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 11
-
- Nitric Oxide and Endothelin Effects 19
-
- Hemodynamic Monitoring and Therapy 8
-
- Pulmonary Hypertension Research and Treatments 6
-
- CRISPR and Genetic Engineering 4
- Co-authors
- Edward D. FreisPeter W. RamwellP. A. KotEdward A. PartenopeLawrence S. LilienfieldThomas M. FitzpatrickRobert T. KelleyThomas F. Higgins
- Journals
- Circulation Research (9 papers)Experimental Biology and Medicine (9 papers)Journal of Pharmacology and Experimental Therapeutics (8 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
John C. Rose
86 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 127
- Biochemistry 185
- Cardiology and Cardiovascular Medicine 400
- Nephrology 99
- Pharmacology 217
- Business and International Management 19
Countries citing papers authored by John C. Rose
This map shows the geographic impact of John C. Rose's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Rose with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Rose more than expected).
Fields of papers citing papers by John C. Rose
This network shows the impact of papers produced by John C. Rose. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Rose. The network helps show where John C. Rose may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John C. Rose, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 15 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 43 | |
| 6 | 2017 | 77 | |
| 7 | 2016 | 16 | |
| 8 | 2014 | 78 | |
| 9 | 2011 | 91 | |
| 10 | 2000 | 18 | |
| 11 | The RHIC 28 MHz RF System | 1997 | 1 |
| 12 | 1984 | 11 | |
| 13 | 1983 | 14 | |
| 14 | 1982 | 8 | |
| 15 | 1978 | 6 | |
| 16 | 1978 | 28 | |
| 17 | 1977 | 10 | |
| 18 | 1957 | 0 | |
| 19 | 1954 | 33 | |
| 20 | 1953 | 2 |
About John C. Rose
John C. Rose is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine and Physiology, having authored 90 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (19 papers), Eicosanoids and Hypertension Pharmacology (15 papers), Inflammatory mediators and NSAID effects (11 papers), Hemodynamic Monitoring and Therapy (8 papers), Cardiovascular Function and Risk Factors (7 papers), Heart Rate Variability and Autonomic Control (6 papers), Pulmonary Hypertension Research and Treatments (6 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Biochemistry (185 citations), Cardiology and Cardiovascular Medicine (400 citations) and Nephrology (99 citations). John C. Rose has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Edward D. Freis, Peter W. Ramwell, P. A. Kot, Edward A. Partenope, Lawrence S. Lilienfield, Thomas M. Fitzpatrick, Robert T. Kelley, Thomas F. Higgins, Martin Johnson and Charles A. Hufnagel. Their work appears in journals such as Circulation Research, Experimental Biology and Medicine, Journal of Pharmacology and Experimental Therapeutics, American Journal of Physiology-Legacy Content and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.